Treffer 1 - 3 von 3 für Suche 'M.E. Luggen', Suchdauer: 0,39s Treffer weiter einschränken
  1. 1
    Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly

    Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Eld... von Chalhoub, N.E., Luggen, M.E.

    Veröffentlicht in Lupus

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study

    Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor in... von E. Feist, S. Fatenejad, S. Grishin, E. Korneva, M.E. Luggen, E. Nasonov, M. Samsonov, J.S. Smolen, R.M. Fleischmann


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study

    Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor in... von Feist, E., Fatenejad, S., Grishin, S., Korneva, E., Luggen, M.E., Nasonov, E., Samsonov, M., Smolen, J.S., Fleischmann, R.M.


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: